2023
DOI: 10.1038/s41598-023-32332-x
|View full text |Cite
|
Sign up to set email alerts
|

Machine learning algorithms reveal potential miRNAs biomarkers in gastric cancer

Abstract: Gastric cancer is the high mortality rate cancers globally, and the current survival rate is 30% even with the use of combination therapies. Recently, mounting evidence indicates the potential role of miRNAs in the diagnosis and assessing the prognosis of cancers. In the state-of-art research in cancer, machine-learning (ML) has gained increasing attention to find clinically useful biomarkers. The present study aimed to identify potential diagnostic and prognostic miRNAs in GC with the application of ML. Using… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
7
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 17 publications
(8 citation statements)
references
References 48 publications
0
7
0
Order By: Relevance
“…MiRNAs, a small, single-stranded, non-coding ribonucleic acids (RNAs), are essential for all biological functions including cancer development. ML provides an opportunity to explore miRNA’s ability to serve as a reliable biomarker targeting drugs and improve cancer clinical classification ( 58 , 59 ).…”
Section: Ai In Cancermentioning
confidence: 99%
“…MiRNAs, a small, single-stranded, non-coding ribonucleic acids (RNAs), are essential for all biological functions including cancer development. ML provides an opportunity to explore miRNA’s ability to serve as a reliable biomarker targeting drugs and improve cancer clinical classification ( 58 , 59 ).…”
Section: Ai In Cancermentioning
confidence: 99%
“…In pursuit of this objective, researchers have increasingly turned to predictive methods, with data mining and machine learning (ML) approaches taking center stage [ 4 - 8 ]. The applicability of ML extends beyond CRC and includes the prediction of survival outcomes in various cancer types, leading to several comparative studies among a subset of these methodologies [ 9 , 10 , 1 , 11 , 12 ].…”
Section: Introductionmentioning
confidence: 99%
“…The Cancer Genome Atlas (TCGA) is a project that maps out the genome variation of human cancerous cells by RNA sequencing and using a non-malignant cell as a reference. These maps have identified many core genetic pathways activated in various cancers 35 , 36 . Therefore, in the current study, we performed gene expression proofing of pancreatic cancer using the TCGA database and Machine learning to identify differential expression genes (DEGs) and differentially expressed miRNAs (DEmiRNA).…”
Section: Introductionmentioning
confidence: 99%